Literature DB >> 36180809

Images in infectious diseases: Monkeypox - images of an exhibition.

Ana M Groh1, Holger F Rabenau2, Christoph Stephan3.   

Abstract

Entities:  

Keywords:  HIV; Men having sex with men; Monkeykox; Skin lesions

Year:  2022        PMID: 36180809      PMCID: PMC9525230          DOI: 10.1007/s15010-022-01924-6

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   7.455


× No keyword cloud information.
A 35-year-old man who has sex with men (MSM) approached his HIV treating physician by email, because of new scrotal skin lesions (Fig. 1A), he noticed the day before, appearing with urethral discharge and left-sided, enlarged inguinal lymph node. Self-administered doxycycline, due to suspected syphilis, did not improve symptoms. HIV was detected in December 2019, and antiretroviral therapy was immediately started; medical and sexual transmitted infections (STI)-history was unremarkable.
Fig. 1

Overtime development of Monkeypox lesions was meticulously documented by the (nurse) patient’s photograph series, after the suspected diagnosis had been mentioned in a first phone call. See detailed diary of skin lesions: A—Day 1 (July 5th, 2022): crater-shaped lesions, see arrow: 2 × 2 mm (diameter); B—Day 3, hardly changed lesions; C—Day 4, the central meltdowns now present enlarged, with more intense redness; D—Day 5, lesions start to dry up; E—Day 10, central redness enlarge and begin to encrust, lesions’ diameter: now 5 × 5 mm; F—Day 15, the lesions are completely covered by reddish crust; G—Day 22, scarring regression, crusts start to fall off; H—Day 27, scarred healing of lesions

Overtime development of Monkeypox lesions was meticulously documented by the (nurse) patient’s photograph series, after the suspected diagnosis had been mentioned in a first phone call. See detailed diary of skin lesions: A—Day 1 (July 5th, 2022): crater-shaped lesions, see arrow: 2 × 2 mm (diameter); B—Day 3, hardly changed lesions; C—Day 4, the central meltdowns now present enlarged, with more intense redness; D—Day 5, lesions start to dry up; E—Day 10, central redness enlarge and begin to encrust, lesions’ diameter: now 5 × 5 mm; F—Day 15, the lesions are completely covered by reddish crust; G—Day 22, scarring regression, crusts start to fall off; H—Day 27, scarred healing of lesions Due to COVID-19 isolation, the first clinical examination was deferred to day 11, revealing four increased circular crater-shaped, scrotal skin elevations with central melting (5 × 5 mm; see Fig. 1E) and no further complaints. Laboratory investigations found slightly elevated C-reactive protein (CRP 1.11 mg/dl, nr < 0.5), normal STI check for syphilis, chlamydia, gonococci and trichomonas, but positive Monkeypox DNA from swap (Ct-value = 18.62; in-house modified LightMix Modular Monkeypox Virus-PCR/TibMolBiol, Roche Diagnostics, Mannheim/Germany; Ct-value ≥ 40 = negative). CD4 cell counts (1007/μl, CD4/CD8-ratio 0.79) were normal and HIV-RNA undetectable. On day 29, all skin lesions were dry, scarred and inactive and no new vesicles occurred. Therefore, health authority-imposed Monkeypox isolation was finally lifted and patient returned to work as elderly care nurse. Nucleic acid assays and electron microscopy (see Fig. 2) may support clinical Monkeypox diagnosis in MSM context [1]. Best supportive care of lesions will be most frequently treatment for immunocompetent individuals, as specific antiviral therapy is unavailable [2]. Facing case numbers in Germany [3], a high level of suspicion for Monkeypox visual diagnosis is warranted and this presentation of overtime skin lesions may help for individual timing assignment.
Fig. 2

Monkeypox virus: Scanning electron microscopy (sample obtained from another individual in Frankfurt). Panel A shows a group of 4 typically box-shaped (Monkey-) Pox viruses, panel B shows measurement procedure outcome (longitudinal diameter = 359 nm)

Monkeypox virus: Scanning electron microscopy (sample obtained from another individual in Frankfurt). Panel A shows a group of 4 typically box-shaped (Monkey-) Pox viruses, panel B shows measurement procedure outcome (longitudinal diameter = 359 nm)
  3 in total

1.  Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022.

Authors:  John P Thornhill; Sapha Barkati; Sharon Walmsley; Juergen Rockstroh; Andrea Antinori; Luke B Harrison; Romain Palich; Achyuta Nori; Iain Reeves; Maximillian S Habibi; Vanessa Apea; Christoph Boesecke; Linos Vandekerckhove; Michal Yakubovsky; Elena Sendagorta; Jose L Blanco; Eric Florence; Davide Moschese; Fernando M Maltez; Abraham Goorhuis; Valerie Pourcher; Pascal Migaud; Sebastian Noe; Claire Pintado; Fabrizio Maggi; Ann-Brit E Hansen; Christian Hoffmann; Jezer I Lezama; Cristina Mussini; AnnaMaria Cattelan; Keletso Makofane; Darrell Tan; Silvia Nozza; Johannes Nemeth; Marina B Klein; Chloe M Orkin
Journal:  N Engl J Med       Date:  2022-07-21       Impact factor: 176.079

2.  Monkeypox in Germany–Initial Clinical Observations.

Authors:  Christian Hoffmann; Heiko Jessen; Christoph Wyen; Sebastian Noe; Peter Kreckel; Siegfried Köppe; Anja-Sophie Krauss; Christoph Schuler; Markus Bickel; Johannes Lenz; Stefan Scholten; Gerd Klausen; Harm-Henning Lindhof; Björn Jensen; Tobias Glaunsinger; Ramona Pauli; Georg Härter; Billy Radke; Stefan Unger; Simone Marquardt; Anja Masuhr; Stefan Esser; Tim-Oliver Flettner; Guido Schäfer; Jochen Schneider; Christoph D Spinner; Christoph Boesecke
Journal:  Dtsch Arztebl Int       Date:  2022-08-12       Impact factor: 8.251

3.  Oral Tecovirimat for the Treatment of Smallpox.

Authors:  Anne Laudisoit; Floribert Tepage; Robert Colebunders
Journal:  N Engl J Med       Date:  2018-11-22       Impact factor: 176.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.